Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

The Associate Director, Brand Counsel serves as a strategic legal partner to Commercial, Medical Affairs, Regulatory Affairs, Market Access, Corporate Affairs, and Compliance. This attorney will help shape the legal and regulatory framework supporting the development, and potential launch and commercialization of Definium assets.

This role requires expertise in pharmaceutical advertising and promotion, strong business judgment, and the ability to navigate novel legal and policy considerations.

Responsibilities

Support Commercial and Brand Legal Strategy

Act as the legal advisor to brand, marketing, market access, and commercialization teams
Partner with cross-functional stakeholders to support launch planning and commercialization strategy
Strategically advise teams on legal risks and offer practical solutions related to brand positioning, customer engagement, and commercialization initiatives
Support development of a best-in-class commercialization model for innovative psychiatric therapies

Materials Review

Serve as a core member of the Promotional Review Committee (PRC) and Medical Review Committee (MRC)
Review and approve promotional materials directed to healthcare professionals, patients, and caregivers
Advise on market-shaping activities, disease education communications, provider engagement strategies, and launch materials
Counsel teams regarding FDA, the Office of Prescription Drug Promotion (OPDP), Federal Trade Commission (FTC), and federal and state law requirements applicable to pharmaceutical promotion
Support legal review of sales training materials, websites and digital assets, print media, speaker program materials, advisory board materials, Medical Affairs materials
Help establish promotional review standards, policies, and governance processes for a pre-commercial organization transitioning to launch

Regulatory & Healthcare Compliance Counseling

Advise stakeholders regarding:
FDA requirements for promotion and scientific exchange
Healthcare fraud and abuse laws
Payment transparency and reporting obligations
Privacy and data protection requirements, including Controlling the Assault of Non-Solicited Pornography and Marketing Act (CAN-SPAM)
Price transparency reporting obligations
PhRMA Code compliance
Strategically partner with Compliance and Regulatory Affairs on risk assessments and mitigation strategies
Monitor emerging legal and regulatory developments affecting psychiatric therapies and novel treatment modalities

Qualifications

Juris Doctor (J.D.) from an accredited law school.
Active membership in at least one U.S. state bar.
Minimum of 5 years of legal experience, including significant pharmaceutical or biotechnology industry experience.
Demonstrated expertise in FDA-regulated advertising and promotion.